-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials As Reported
- accession Number 0001326110-23-000064
- accounts Payable Current 33,573,000
- accumulated Depreciation Depletion And Amortization Property Plant And Equipment 73,415,000
- accumulated Other Comprehensive Income Loss Net Of Tax --33,000
- allocated Share Based Compensation Expense 10,878,000
- amendment Flag false
- assets 343,400,000
- assets Current 113,486,000
- cash And Cash Equivalents At Carrying Value 88,481,000
- cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --16,160,000
- cik 1,326,110
- city Area Code 844
- common Stock Par Or Stated Value Per Share 0.0001
- common Stock Shares Authorized 900,000,000
- common Stock Shares Issued 435,923,104
- common Stock Shares Outstanding 421,569,115
- current Fiscal Year End Date --12-31
- date Filed 2023-05-11
- depreciation 4,200,000
- depreciation Depletion And Amortization 4,681,000
- document Fiscal Period Focus Q1
- document Fiscal Year Focus 2,023
- document Period End Date 2023-03-31
- document Transition Report false
- document Type 10-Q
- earnings Per Share Basic -0.27
- earnings Per Share Diluted -0.27
- entity Address Address Line 1 3530 John Hopkins Court
- entity Address City Or Town San Diego
- entity Address Postal Zip Code 92,121
- entity Address State Or Province CA
- entity Central Index Key 1,326,110
- entity Current Reporting Status Yes
- entity Emerging Growth Company false
- entity File Number 001-37507
- entity Filer Category Non-accelerated Filer
- entity Incorporation State Country Code DE
- entity Interactive Data Current Yes
- entity Name ImmunityBio, Inc.
- entity Registrant Name IMMUNITYBIO, INC.
- entity Shell Company false
- entity Small Business true
- entity Tax Identification Number 43-1979754
- finance Lease Liability 122,000
- finance Lease Liability Current 79,000
- finance Lease Liability Current Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilitiesCurrent
- finance Lease Liability Noncurrent 43,000
- finance Lease Liability Noncurrent Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
- finance Lease Liability Payments Due 132,000
- finance Lease Liability Payments Due Next Twelve Months 66,000
- finance Lease Liability Payments Due Year Four 0
- finance Lease Liability Payments Due Year Three 0
- finance Lease Liability Payments Due Year Two 0
- finance Lease Liability Undiscounted Excess Amount 10,000
- finance Lease Right Of Use Asset 115,000
- finance Lease Right Of Use Asset Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
- income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest --116,583,000
- income Taxes Paid Net 0
- income Tax Expense Benefit 0
- interest Expense 29,816,000
- interest Paid Net 15,515,000
- irs Number 431,979,754
- lessee Operating Lease Liability Payments Due 72,758,000
- lessee Operating Lease Liability Payments Due Next Twelve Months 12,119,000
- lessee Operating Lease Liability Payments Due Year Four 8,209,000
- lessee Operating Lease Liability Payments Due Year Three 10,290,000
- lessee Operating Lease Liability Payments Due Year Two 12,145,000
- lessee Operating Lease Liability Undiscounted Excess Amount 20,684,000
- liabilities 875,116,000
- liabilities And Stockholders Equity 343,400,000
- liabilities Current 564,945,000
- local Phone Number 696-5235
- marketable Securities Current 2,787,000
- marketable Securities Noncurrent 820,000
- net Cash Provided By Used In Financing Activities 76,888,000
- net Cash Provided By Used In Investing Activities --8,484,000
- net Cash Provided By Used In Operating Activities --84,300,000
- net Income Loss --116,343,000
- nonoperating Income Expense --5,003,000
- operating Expenses 111,940,000
- operating Income Loss --111,580,000
- operating Lease Cost 2,921,000
- operating Lease Liability 49,133,000
- operating Lease Liability Current 2,844,000
- operating Lease Liability Noncurrent 46,289,000
- operating Lease Payments 3,179,000
- operating Lease Right Of Use Asset 44,191,000
- other Assets Current 4,428,000
- other Assets Noncurrent 4,545,000
- other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax --226,000
- other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent --116,559,000
- other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax --6,000
- other Liabilities Noncurrent 462,000
- other Nonoperating Income Expense --1,077,000
- payments Related To Tax Withholding For Share Based Compensation 357,000
- payments To Acquire Property Plant And Equipment 8,428,000
- period End 1,680,220,800,000
- period Start 1,672,531,200,000
- proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 0
- property Plant And Equipment Gross 227,580,000
- property Plant And Equipment Net 154,165,000
- report Link https://www.sec.gov/Archives/edgar/data/1326110/000132611023000064/ibrx-20230331_htm.xml
- research And Development Expense 79,264,000
- retained Earnings Accumulated Deficit --2,500,000,000
- selling General And Administrative Expense 32,676,000
- share Based Compensation 10,878,000
- stockholders Equity --528,983,000
- trading Symbol IBRX
- update 1970-01-01
- variable Lease Cost 970,000
- weighted Average Number Of Diluted Shares Outstanding 428,381,485
- weighted Average Number Of Shares Outstanding Basic 428,381,485
- id REPORTED_FINANCIALS
- key IBRX
- subkey 10-Q
- date 2023-05-11
- updated 2023-05-12
-
Symbol Info
-
Symbol Over View
-
Technical Analysis